0001127602-23-025164.txt : 20231003 0001127602-23-025164.hdr.sgml : 20231003 20231003161452 ACCESSION NUMBER: 0001127602-23-025164 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230930 FILED AS OF DATE: 20231003 DATE AS OF CHANGE: 20231003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Theagene Jean-Manasse CENTRAL INDEX KEY: 0001969857 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41455 FILM NUMBER: 231303786 MAIL ADDRESS: STREET 1: 500 PLACE D ARMES STREET 2: SUITE 1800 CITY: MONTREAL STATE: A8 ZIP: H2Y 2W2 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MAIA Biotechnology, Inc. CENTRAL INDEX KEY: 0001878313 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 444 WEST LAKE STREET, SUITE 1700 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: 312-416-8592 MAIL ADDRESS: STREET 1: 444 WEST LAKE STREET, SUITE 1700 CITY: CHICAGO STATE: IL ZIP: 60606 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2023-09-30 0001878313 MAIA Biotechnology, Inc. MAIA 0001969857 Theagene Jean-Manasse 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 1 0 Stock Options 2.20 2023-09-30 4 A 0 8378 0 A 2023-09-30 2033-09-30 Common Stock 8378 8378 D The stock options, granted on September 30, 2023 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date. /s/ Jean-Manasse Theagene 2023-10-03